MTHFR and myeloid sarcoma: When comparing the MS between cases and controls, we found a statistically significant hypermethylation of the AXIN1 (p = 0.036) and MTHFR (p = 0.041) genes in the control group, which could suggest that hypermethylation is a protective mechanism against CHD.